Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Opinion in Chemical Biology|August 28, 2003
Advances in pain therapeuticsPhilip LoGrasso, Jeffrey McKelvyThe Journal of Infectious Diseases|January 27, 2012
Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antiviralsHaihong Zhu, Flossie Wong-Staal, Haekyung Lee, et al.Bioorganic & Medicinal Chemistry Letters|October 8, 2011
Discovery of highly potent small molecule Hepatitis C Virus entry inhibitorsGopi Kumar Mittapalli, Andrew Jackson, Fang Zhao, et al.Antiviral Therapy|September 8, 2012
ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detectionJill Hochreiter, Jill Lapham, Flossie Wong-Staal, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2012
Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitorGopi Kumar Mittapalli, Fang Zhao, Andrew Jackson, et al.Journal of Hepatology|October 12, 2010
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitorsAndrew J Syder, Haekyung Lee, Mirjam B Zeisel, et al.Pageof 1